Revolution Medicines (RVMD) Research & Development (2019 - 2025)
Historic Research & Development for Revolution Medicines (RVMD) over the last 7 years, with Q3 2025 value amounting to $262.5 million.
- Revolution Medicines' Research & Development rose 7298.36% to $262.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $880.5 million, marking a year-over-year increase of 5916.62%. This contributed to the annual value of $592.2 million for FY2024, which is 3995.83% up from last year.
- Per Revolution Medicines' latest filing, its Research & Development stood at $262.5 million for Q3 2025, which was up 7298.36% from $224.1 million recorded in Q2 2025.
- In the past 5 years, Revolution Medicines' Research & Development ranged from a high of $262.5 million in Q3 2025 and a low of $40.9 million during Q1 2021
- In the last 5 years, Revolution Medicines' Research & Development had a median value of $98.0 million in 2023 and averaged $113.1 million.
- Data for Revolution Medicines' Research & Development shows a peak YoY increase of 12453.91% (in 2023) and a maximum YoY decrease of 2205.17% (in 2023) over the last 5 years.
- Over the past 5 years, Revolution Medicines' Research & Development (Quarter) stood at $53.7 million in 2021, then increased by 23.19% to $66.1 million in 2022, then skyrocketed by 124.54% to $148.5 million in 2023, then grew by 26.68% to $188.1 million in 2024, then surged by 39.56% to $262.5 million in 2025.
- Its Research & Development was $262.5 million in Q3 2025, compared to $224.1 million in Q2 2025 and $205.7 million in Q1 2025.